Coverage Initiated on Healthcare Stocks Valeant Pharma, Merus Labs, Nobilis Health, and Concordia

LONDON, UK / ACCESSWIRE / July 25, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the technical notes impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare industry. Companies recently under review include Valeant Pharma, Merus Labs International Inc., Nobilis Health, and Concordia Intl. Get all of our research notes free by signing up at: http://www.activewallst.com/register/.

On Friday, July 22, 2016, the TSX Composite Index edged 0.24% higher, to finish at 14,600.66. The Health Care Index, on the other hand, was down 2.48% at 250.13 at the closing bell.

Active Wall St. has initiated notes on the following equities: Valeant Pharmaceuticals International Inc. (TSX: VRX), Merus Labs International Inc. (TSX: MSL), Nobilis Health Corporation (TSX: NHC), and Concordia International Corporation (TSX: CXR). Register with us now for your free membership and more at: http://www.activewallst.com/register/.

Valeant Pharmaceuticals International Inc. (TSX: VRX)

On Friday, shares in Laval, Canada headquartered Valeant Pharmaceuticals International Inc. ended the session 6.24% lower at $30.03 with a total volume of 1.03 million shares traded. Valeant Pharmaceuticals International’s shares, which develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices globally, have gained 5.96% in the last one month. The stock is trading above its 50-day moving average. The company’s 200-day moving average of $63.93 is greater than its 50-day moving average of $29.41. See our notes on VRX.TO at: http://www.activewallst.com/registration-3/?symbol=VRX.

Merus Labs International Inc. (TSX: MSL)

On Friday, shares in Toronto, Canada headquartered specialty pharmaceutical company, Merus Labs International Inc., recorded a trading volume of 840,586 shares, which was higher than their three months average volume of 454,753 shares. The stock ended the day 3.55% higher at $1.75. Merus Labs International Inc.’s stock has gained 8.02% in the last one month. Shares of the Company, which engages in the acquisition of prescription medicines primarily in Canada and Europe, are trading above its 50-day moving average. The company stock’s 200-day moving average of $1.82 is above its 50-day moving average of $1.64. The complimentary notes on MSL.TO at: http://www.activewallst.com/registration-3/?symbol=MSL.

Nobilis Health Corp. (TSX: NHC)

Houston, Texas-based Nobilis Health Corp.’s stock finished Friday’s session 1.53% higher at $3.31 with a total volume of 207,445 shares traded. The stock has gained 8.88% in the last one month. Shares of the Company, which owns and manages ambulatory surgical centers and surgical hospitals in the U.S., are trading above its 50-day moving average. Nobilis Health’s 200-day moving average of $3.76 is above its 50-day moving average of $3.09. The stock traded at a PE ratio of 5.20. Register for free and access the latest notes on NHC.TO at: http://www.activewallst.com/registration-3/?symbol=NHC.

Concordia International Corp. (TSX: CXR)

Oakville, Canada headquartered specialty pharmaceutical company, Concordia International Corp.’s stock fell 4.45%, to close the day at $25.55. The stock recorded a trading volume of 757,272 shares. Shares of the company’s are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $36.01 is greater than its 50-day moving average of $28.35. Get free access to your notes on CXR.TO at: http://www.activewallst.com/registration-3/?symbol=CXR.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442777